MedPath

Study of the effectiveness of mosapride for GERD patients with sleep disorders

Not Applicable
Recruiting
Conditions
Gastroesophageal Reflux Disease
Registration Number
JPRN-UMIN000012363
Lead Sponsor
Department of Gastroenterology , Shimane University School of Medicine
Brief Summary

Discontinuation of the test

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
0
Inclusion Criteria

Not provided

Exclusion Criteria

Example that started the oral sleep-inducing agent within two weeks. Patients with serious underlying disease that affect sleep. Examples are allergic to mosapride. Examples of oral administration of the drug combination and attention mosapride. Examples of oral medicine in the related to gastrointestinal motor function. Patients with psychiatric disorders. Examples of surgical procedures after the gastroesophageal. Example pregnant or nursing. Example not be obtained consent. Example the attending physician is deemed inappropriate.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath